Tofacitinib
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
National Institute of Respiratory Diseases, Mexico
Overview
Tofacitinib is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Tofacitinib clinical trials
Explore related
Medical disclaimer. This page summarizes research about Tofacitinib for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.